ARK Investment Management - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 38 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q3 2019$105,000
-68.8%
144,414
+86.7%
0.00%
-75.0%
Q2 2019$336,000
-17.8%
77,348
+38.5%
0.01%
-33.3%
Q1 2019$409,000
-43.7%
55,838
-42.1%
0.01%
-60.0%
Q4 2018$727,000
+19.4%
96,370
-10.6%
0.03%
+66.7%
Q3 2018$609,000107,7610.02%
Other shareholders
INTEC PHARMA LTD JERUSALEM shareholders Q3 2019
NameSharesValueWeighting ↓
Taylor Frigon Capital Management LLC 414,471$302,0000.22%
MEITAV INVESTMENT HOUSE LTD 2,424,516$1,694,0000.12%
Harel Insurance Investments & Financial Services Ltd. 530,573$387,0000.02%
Virtu Financial LLC 131,642$96,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 65,649$48,0000.00%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,460,000$1,064,0000.00%
ARK Investment Management 144,414$105,0000.00%
ETF MANAGERS GROUP, LLC 61,558$46,0000.00%
A.R.T. Advisors, LLC 47,576$35,0000.00%
HRT FINANCIAL LP 29,807$21,0000.00%
View complete list of INTEC PHARMA LTD JERUSALEM shareholders